Second, we only focused on five common polymorphisms, and is encouraged to examine more polymorphisms, especially the low-penetrance polymorphisms from other promising cancer-susceptibility genes, such as PTGS2 and CYP2E1 genes [23]. This evidence concerns the gene CYP2E1 and cancer.